| 2025-03-17 |
3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat |
Geroscience. 2025 Mar 17;Article in Press. |
 |
| 2024-12-03 |
Transplantation of exosomes derived from human wharton's jelly mesenchymal stromal cells enhances functional improvement in stroke rats |
Cell Transplantation. 2024 Dec 03;Article in Press. |
|
| 2024-10-08 |
Neuroprotective effects of psilocybin in a rat model of stroke |
BMC Neuroscience. 2024 Oct 08;25:Article number 49. |
|
| 2024-04-04 |
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease |
GeroScience. 2024 Apr 04;Article in Press. |
|
| 2024-03-27 |
Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: Relevance for neurodegenerative disorders |
GeroScience. 2024 Mar 27;Article in Press. |
|
| 2023-09-21 |
Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein |
PLoS ONE. 2023 Sep 21;18(9):Article number e0291927. |
|
| 2023-05-19 |
Prosaposin PS18 reduces dopaminergic neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease |
Scientific Reports. 2023 May 19;13:Article number 8148. |
|
| 2023-02-22 |
Herbal formula PM012 induces neuroprotection in stroke brain |
PLoS ONE. 2023 Feb 22;18(2):Article number e0281421. |
|
| 2021-11-08 |
Alleviation of methamphetamine snsitization by partially lesioning dopaminergic terminals with 6-hydroxydopamine in nucleus accumbens |
Cell Transplantation. 2021 Nov 8;30:Article in Press. |
|
| 2021-09-13 |
Human milk oligosaccharide 2′-fucosyllactose induces neuroprotection from intracerebral hemorrhage stroke |
International Journal of Molecular Sciences. 2021 Sep 13;22(18):Article number 9881. |
|
| 2021-07 |
Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice |
CNS Neuroscience & Therapeutics. 2021 Jul;27(7):831-841. |
|
| 2021-06-21 |
Administration of AAV-alpha synuclein NAC antibody improves locomotor behavior in rats overexpressing alpha synuclein |
Genes. 2021 Jun 21;12(6):Article number 948. |
|
| 2020-10 |
Human milk Oligosaccharide 2 '-Fucosyllactose reduces neurodegeneration in stroke brain |
Translational Stroke Research. 2020 Oct;11:1001-1011. |
|
| 2020-09-25 |
Protective effect of CXCR4 antagonist CX807 in a rat model of hemorrhagic stroke |
International Journal of Molecular Sciences. 2020 Sep 25;21(19):Article number 7085. |
|
| 2020-08-11 |
PT320, sustained-release exendin-4, mitigates L-DOPA-Induced dyskinesia in a rat 6-Hydroxydopamine model of Parkinson’s disease |
Frontiers in Neuroscience. 2020 Aug 11;14:Article number 785. |
|
| 2020-03-11 |
Downregulation of alpha-synuclein protein levels by an intracellular single-chain antibody |
Journal of Parkinson's Disease. 2020 Mar 11;10(2):573-590. |
|
| 2020-02-21 |
Post-treatment with posiphen reduces endoplasmic reticulum stress and neurodegeneration in stroke brain |
iScience. 2020 Feb 21;23(2):Article number 100866. |
|
| 2019-08 |
Pifithrin-alpha reduces methamphetamine neurotoxicity in cultured dopaminergic neurons |
Neurotoxicity Research. 2019 Aug;36(2 SI):347-356. |
|
| 2019-07 |
Enhanced survival of human-induced pluripotent stem cell transplant in parkinsonian rat brain by locally applied cyclosporine |
Brain Circulation. 2019 Jul-Sep;5(3):130-133. |
|
| 2019-05-30 |
NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats |
Brain Research. 2019 May 30;1719:124-132. |
|
| 2018-11 |
Neuroprotective action of human Wharton's Jelly-Derived mesenchymal stromal cell transplants in a rodent model of stroke |
Cell Transplantation. 2018 Nov;27(11):1603-1612. |
|
| 2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease |
Scientific Reports. 2018 Jul 16;8:Article number 10722. |
|
| 2018-07-16 |
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease [Erratum: Scientific Reports. 2018 Jul 16;8:Article number 10722.] |
Scientific Reports. 2018 Jul 16;8:Article number 13953. |
|
| 2018-07 |
Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury |
Brain Circulation. 2018 Jul-Sep;4(3):124-127. |
|
| 2017-09 |
Improving neurorepair in stroke brain through endogenous neurogenesis-enhancing drugs |
Cell Transplantation. 2017 Sep;26(9):1596-1600. |
|
